Published in Blood Weekly, August 11th, 2005
"Target organs express antigens directly recognized by antigen-specific T cells, thereby precipitating rejection," scientists in Italy explained. "When early T-cell activation is inhibited, there is a low risk of rejection."
In their study, E. Gotti and coauthors working at the Mario Negri Institute for Pharmacological Research "sought to determine the predictive values of serial posttransplant blood cyclosporine trough (C0 ) concentrations to minimize the risk for a first rejection episode compared with 2-hour postdose (C2 )...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.